Ticagrelor and Urinary tract infection - a phase IV clinical study of FDA data


Urinary tract infection is found among people who take Ticagrelor, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Ticagrelor and have Urinary tract infection. It is created by eHealthMe based on reports of 6,456 people who have side effects when taking Ticagrelor from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 16, 2022

6,456 people reported to have side effects when taking Ticagrelor.
Among them, 41 people (0.64%) have Urinary tract infection.

What is Ticagrelor?

Ticagrelor has active ingredients of ticagrelor. eHealthMe is studying from 6,470 Ticagrelor users for its effectiveness, alternative drugs and more.

What is Urinary tract infection?

Urinary tract infection is found to be associated with 3,965 drugs and 3,657 conditions by eHealthMe.

Number of Ticagrelor and Urinary tract infection reports submitted per year:

Could Ticagrelor cause Urinary tract infection?

Time on Ticagrelor when people have Urinary tract infection *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Urinary tract infection when taking Ticagrelor *:

  • female: 78.79 %
  • male: 21.21 %

Age of people who have Urinary tract infection when taking Ticagrelor *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 20.59 %
  • 50-59: 2.94 %
  • 60+: 76.47 %

Common drugs people take besides Ticagrelor *:

  1. Asa: 17 people, 41.46%
  2. Pantoprazole: 15 people, 36.59%
  3. Tylenol: 12 people, 29.27%
  4. Rituxan: 9 people, 21.95%
  5. Actonel: 8 people, 19.51%
  6. Plavix: 7 people, 17.07%
  7. Adalat Cc: 6 people, 14.63%
  8. Crestor: 6 people, 14.63%
  9. Amlodipine: 5 people, 12.20%
  10. Metformin: 5 people, 12.20%

Common side effects people have besides Urinary tract infection *:

  1. Heart Attack: 24 people, 58.54%
  2. Pneumonia: 18 people, 43.90%
  3. Hypotension (abnormally low blood pressure): 17 people, 41.46%
  4. General Physical Health Deterioration (weak health status): 16 people, 39.02%
  5. Weakness: 16 people, 39.02%
  6. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 16 people, 39.02%
  7. Basal Cell Carcinoma (a skin cancer, it rarely metastasizes or kills): 16 people, 39.02%
  8. Balance Disorder: 15 people, 36.59%
  9. Oxygen Saturation Decreased: 15 people, 36.59%
  10. Hypersensitivity: 15 people, 36.59%

Common conditions people have *:

  1. Polymyositis (inflammatory muscle disease that causes weakness of the skeletal muscles): 15 people, 36.59%
  2. High Blood Pressure: 10 people, 24.39%
  3. Diabetes: 5 people, 12.20%
  4. Pain: 4 people, 9.76%
  5. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 4 people, 9.76%
  6. High Blood Cholesterol: 4 people, 9.76%
  7. Cardiac Disorder: 3 people, 7.32%
  8. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 7.32%
  9. Depression: 3 people, 7.32%
  10. Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 7.32%

* Approximation only. Some reports may have incomplete information.

Do you take Ticagrelor and have Urinary tract infection?

Check whether Urinary tract infection is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Urinary tract infection and when was it recovered:

Expand to all the drugs that have ingredients of ticagrelor:

Alternative drugs to, pros and cons of Ticagrelor:

Common Ticagrelor side effects:

Browse all side effects of Ticagrelor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Urinary tract infection treatments and more:

COVID vaccines that are related to Urinary tract infection:

Common drugs associated with Urinary tract infection:

All the drugs that are associated with Urinary tract infection:

Common conditions associated with Urinary tract infection:

All the conditions that are associated with Urinary tract infection:

How the study uses the data?

The study uses data from the FDA. It is based on ticagrelor (the active ingredients of Ticagrelor) and Ticagrelor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: